Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +35.20%
#3 Velvet Velvet +24.01%
#4 Akedo Akedo +19.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#6 Fake World Assets Fake World Assets +16.68%
#7 DoubleZero DoubleZero +13.22%
#8 clBTC clBTC +11.84%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.39%
#10 HOME HOME +10.84%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Rang in Aktien #39944
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Aktienkurs
$0.00366968
Zuletzt synchronisiert: 2024-07-23
Marktkapitalisierung
$291.42K
Veränderung (1 Tag)
-0.81%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Bioasis Technologies Inc. (BTI)

Kategorie

Healthcare
Preis BTI mit Marktkapitalisierung von B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Marktkapitalisierung von Bioasis Technologies Inc.(BTI)
Marktkapitalisierung: $291.42K
Mit Stand August 2026 hat Bioasis Technologies Inc. eine Marktkapitalisierung von $291.42K. Das macht Bioasis Technologies Inc. laut unseren Daten zum 39944th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Bioasis Technologies Inc. von 2008 bis 2026
BTI im Vergleich zu den Top 5 der beliebtesten stocks
Preis für BTI Vermögenswert B Marktkapitalisierung von B Ergebnisse
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
Apple Inc. Apple Inc.
AAPL
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +979,445,505.37%